Jeff Silber

Equibles does not estimate personal net worth.

Get an email with a short summary when Ironwood Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.

Get IRWD alerts

About Jeff Silber

Jeff Silber has spoken on 1 earnings call across 1 company, most recently for Ironwood Pharmaceuticals Inc on November 5, 2026. Ironwood Pharmaceuticals Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Ironwood Pharmaceuticals Inc includes Tammi Gaskins (CEO and Board Member), Julie McHugh (Chairman and Board Member), Gregory Martini (CFO) and 7 others.

Jeff Silber on recent calls

“We continue to advance STARS-2, our randomized, double-blind, placebo-controlled, 24-week, confirmatory phase 3 trial, evaluating apiglutide in adults with short bowel syndrome with intestinal failure, or SBS-IF.”

Other, Ironwood Pharmaceuticals Q3 2026 Investor Update Conference Call · November 5, 2026

Affiliation history

Ironwood Pharmaceuticals Inc (IRWD)
Transcript header (unverified)

Current

Company network

Ironwood Pharmaceuticals Inc

IRWD

Current role

Drug Manufacturers - Specialty & Generic · Healthcare

1 appearance Latest appearance 2026-11-05

View calls and events

Leadership on record at Ironwood Pharmaceuticals Inc

Tammi Gaskins CEO, Board Member
Julie McHugh Chairman, Board Member
Gregory Martini CFO
Jason Rickard CFO
Ronald Silver CFO, Chief Accounting Officer
Thomas McCourt CFO, Board Member
Sravan K. Emany COO
Gina Consylman Chief Accounting Officer
Alexander Denner Board Member
Alexander Denner, Ph.D. Board Member

Recent activity

Earnings call Ironwood Pharmaceuticals Q3 2026 Investor Update Conference Call Ironwood Pharmaceuticals Inc (IRWD)
2026-11-05